0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover9885.21%IV236.32%PremiumMay 17, 2024Expiry Date5.27Intrinsic Value100Multiplier-5DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type-0.8838Delta0.1172Gamma--Leverage Ratio-6.4706Theta0.0000Rho0.00Eff Leverage0.0000Vega
Nanoviricides Stock Discussion
NEWS
NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc
NanoViricides has engaged Aagami Inc. to seek licensing and partnering opportunities for its key asset, NV-387, and platform technology in India and Japan. NV-387, a broad-spectrum antiviral nanomedicine, has completed Phase I clinical trials in healthy subjects with no adverse effects reported. It is now ready for Phase II trials.
NV-387, designed to mimic host-side virus-binding features, targets a wi...
WTB $Nanoviricides(NNVC.US)$ ty
NEWS
A Novel Broad-Spectrum Antiviral with Activity Against RSV
NanoViricides announced that its antiviral drug candidate, NV-387, showed complete survival in mice lethally infected with RSV (Respiratory Syncytial Virus) in a recent study.
The study compared NV-387 with the currently approved RSV treatment, ribavirin. While NV-387 led to the complete survival of animals over a 21-day period, ribavirin resulted in the death of all subjects by day 14.
RSV is a major cause ...
$Nanoviricides(NNVC.US)$
$Tenet Healthcare(THC.US)$
I want to watch these the most, I think, and now to find stuff in a different sector..
NEWS
A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
NanoViricides, Inc. announces NV-387, a novel broad-spectrum antiviral with activity against Smallpox/Mpox. NV-387 shows strong orthopoxvirus activity against Smallpox/Mpox, both inhalation and skin abrasion modes. Animal studies demonstrate increased survival compared to tecovirimat, approved for Smallpox. NV-387 potentially reduces tecovirimat resistance. NanoViricides focuses on developing antiv...
NanoViricides Inc: Ultra-Broad Antiviral Activity Spectrum of NV-387 Includes Influenza a Viruses, Possibly Including Bird Flu H5N1 Virus as Well! NanoViricides: Anti-Influenza Activity of NV-387 Given Orally Substantially Superior to All 3 Approved Anti-Influenza Drugs
Accesswire· 3 mins ago
These guys might have the worst website I have seen since geocities. Its as if you took their code and put it into notepad.
Fortunately thats the worst experience Ive had with them. Their product is fascinating, if it really works it really could be the end ofvirus trouble. It works by mimicking human cell signatures. Fucking cool.
Accesswire· 1 min ago
No comment yet